Abstract
Head and Neck Cancer (HNC) is the set of tumors that have mostly origin in squamous cells. It ranks 6th among the most common cancers in the world and each year, it is estimated that more than 633,000 new cases are diagnosed. Approximately 75% of the cases present the disease in an advanced stage (III and IV), for which the prognosis is poor. In the usual treatment, cisplatin chemotherapy…